Pyxis Oncology
PYXS----
全部股東
股東類型
- 公眾及其他56.56%
- 創投/私募18.90%
- 機構投資者14.43%
- 對沖基金6.56%
- 個人與內幕人士3.56%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
GordonMD Global Investments LP | 13.01% | 1,554.19 萬 | 2.79% | +551.70 萬 | |
BVF Partners L.P. | 6.56% | 784.01 萬 | -- | +784.01 萬 | |
Pfizer Venture Investments LLC | 5.89% | 703.28 萬 | 5.31% | +0 | 30/06/2026 |
Laurion Capital Management LP | 4.10% | 490.09 萬 | 3.85% | -9.64 萬 | 30/06/2026 |
Vanguard Capital Management, LLC | 1.99% | 237.90 萬 | 1.72% | +4.46 萬 | 30/06/2026 |
Lara SullivanFormer CEO, President, Chief Medical Officer & Director | 1.56% | 186.65 萬 | 1.41% | +0 | 20/04/2026 |
Healthinvest Partners AB | 0.81% | 96.65 萬 | 0.17% | +34.92 萬 | 30/06/2026 |
BlackRock, Inc. | 0.73% | 86.79 萬 | 0.53% | +7.91 萬 | 30/06/2026 |
Palo Alto Investors LP | 0.72% | 86.43 萬 | 0.88% | -14.62 萬 | 30/06/2026 |
Marshall Wace LLP | 0.70% | 83.05 萬 | 0.13% | +47.61 萬 | 30/06/2026 |
Pamela ConnealyFormer CFO & COO | 0.67% | 80.62 萬 | 0.61% | +0 | |
Renaissance Technologies LLC | 0.65% | 77.22 萬 | 0.77% | -11.64 萬 | 30/06/2026 |
Geode Capital Management, LLC | 0.50% | 59.18 萬 | 0.46% | -6,272.00 | 30/06/2026 |
Woodline Partners LP | 0.44% | 52.40 萬 | -- | +52.40 萬 | 30/06/2026 |
683 Capital Management, LLC | 0.38% | 45.94 萬 | 1.04% | -43.69 萬 | 30/06/2026 |
Jacobs Levy Equity Management Inc | 0.36% | 42.86 萬 | 0.37% | -3.24 萬 | 30/06/2026 |
John FlavinLead Independent Director | 0.35% | 41.30 萬 | 0.31% | +0 | 20/04/2026 |
Longaeva Partners L.P. | 0.30% | 35.36 萬 | 0.50% | -14.96 萬 | 30/06/2026 |
Decheng Capital LLC | 0.27% | 32.68 萬 | 0.25% | +0 | 30/06/2026 |
Jitendra WadhaneChief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial Officer | 0.27% | 32.14 萬 | 0.24% | -615.00 | 20/04/2026 |